Search

  • Search

    Invitation to tender for the Provision of a Digital PCR Platform, Associated Reagents and Support for Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

    St James's Hospital

    Invitation to tender for the Provision of a Digital PCR Platform, Associated Reagents and Support for Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

    1. Competition notice published

      Oct 8, 6:33 AMOctober 8, 2026 6:33 AM

    2. Questions deadline

      Nov 3, 3:00 PMNovember 3, 2026 3:00 PM

    3. Tender submission deadline

      Nov 10, 11:00 AMNovember 10, 2026 11:00 AM

    4. Opening date

      Nov 10, 11:30 AMNovember 10, 2026 11:30 AM

    5. Tender validity period

      Feb 8, 11:00 AMFebruary 8, 2027 11:00 AM

    Brief

    Ireland: Tenders/St James's Hospital/Invitation to tender for the Provision of a Digital PCR Platform, Associated Reagents and Support for Cancer Molecular Diagnostics Department within St James’s Hospital Dublin
    Brief

    St James's Hospital needs a digital PCR platform, including all hardware, software, and ancillary equipment, along with associated reagents and support, for its Cancer Molecular Diagnostics Department in Dublin. The contract duration is 54 months, with a maximum total value of 250,000 EUR. The purchase includes a minimum three-year comprehensive warranty, installation, commissioning, and training. The platform will be used for assay development, evaluation, and method transfer, with an agreed quantity/value of development reagents and consumables to be drawn down over the three-year agreement.

    About the bid

      The Contracting Authority (CA) seeks to purchase one digital PCR instrument, including all hardware, software and ancillary equipment required for routine operation. The purchase shall include a minimum three-year comprehensive warranty, installation, commissioning and training.The CA intends initially to use the platform for assay development, evaluation and method transfer and wishes to purchase an agreed quantity/value of development reagents and consumables at the commencement of the contract. These reagents shall be available for draw-down by the laboratory as required over the three-year agreement. During the course of the agreement, the CA may elect to develop new assays or migrate selected existing molecular diagnostic assays to dPCR where this provides appropriate clinical, analytical or operational benefit. The extent and timing of such migration will be determined by the CA according to clinical and service requirements and does not represent a commitment to implement any specific assay or purchase any minimum quantity of reagents.

      Contact phone
      104162468
      Contact email
      dgunning@stjames.ie
      Address
      James Street, D08 NHY1 Dublin

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

      Found no award criteria in the contract notice.

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    St James's Hospital
    Title
    Invitation to tender for the Provision of a Digital PCR Platform, Associated Reagents and Support for Cancer Molecular Diagnostics Department within St James’s Hospital Dublin
    Type
    CompetitionPrequalification
    Main code
    38000000Laboratory, optical and precision equipments (excl. glasses)
    Supplemental codes

    No supplemental codes from buyer…

    Supplemental codes added by Cobrief

    33696500Laboratory reagents
    38430000Detection and analysis apparatus
    38950000Polymerase Chain Reaction (PCR) equipment
    Location
    Dublin
    Estimated value
    €250,000.00
    Duration
    54 months

    Active similar competitions

    • St James's Hospital

      Laboratorie- og analyseutstyr

      Invitation to tender for the provision of a Next Gen Sequencing Platform for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

      St James's Hospital needs a Next Gen Sequencing Platform for the Cancer Molecular Diagnostics Department in Dublin for 60 months, with a maximum total value of 1,850,000 EUR. BioSciences Limited a Thermo Fisher Company likely has a similar contract today.

      CompetitionSep 24, 2026
      Oct 29, 2026(19 days)
      €1,850,000

    • St James's Hospital

      Laboratorie- og analyseutstyr

      The Provision of a Coagulation Analytical Platform for the St James’s Hospital Coagulation Laboratory incorporating the National Centre for Hereditary Coagulation Disorders. at St James’s Hospital.

      St James's Hospital needs a coagulation analytical platform for the St James’s Hospital Coagulation Laboratory, incorporating the National Centre for Hereditary Coagulation Disorders, for 7 years, with a maximum total value of 4,550,000 EUR. The goods are to be delivered in Dublin, Ireland.

      CompetitionSep 23, 2026
      Oct 28, 2026(18 days)
      €4,550,000

    • Sykehusinnkjøp Hf

      Medisinsk og laboratorieutstyr

      NGS sekvenseringsplattform til avd. for patologi ved St. Olavs hospital HF

      Sykehusinnkjøp Hf planlegger anskaffelsen av en helautomatisert NGS-sekvenseringsplattform for avdeling for patologi ved St. Olavs hospital HF, som skal utvide og videreutvikle dagens analysekapasitet for klinisk diagnostikk av DNA og RNA fra FFPE-prøver og ctDNA. Løsningen skal være en samlet plattform som håndterer hele prosessen fra bibliotekspreparering til sekvensering, bioinformatisk analyse og rapportering, og skal være tilgjengelig med CE-IVD/IVDR-godkjente paneler der dette foreligger. Thermo Fisher Diagnostics AS har sannsynligvis kontrakten i dag.

      PlanningOct 8, 2026
      Feb 1, 2027(114 days)
      NOK 0

    • Oslo Universitetssykehus Hf

      Engroshandel med medisinske og husholdningsvarer

      78129 RH KLM IMM Produksjonsinstrument for celleterapi

      Oslo Universitetssykehus HF trenger et produksjonsinstrument for celleterapi, med opsjon på ytterligere ett instrument, programvare og forbruksmateriell, samt serviceavtaler, for en periode på 10 år. Instrumentet skal brukes til GMP-kompatibel sluttprosessering av celleterapiprodukter (ATMP), inkludert CAR-T-celler, ved Rikshospitalet i Oslo. Løsningen skal støtte en standardisert, automatisert og funksjonelt lukket arbeidsflyt for sluttprosessering, og bidra til redusert operatøravhengighet og kontaminasjonsrisiko. Miltenyi Biotech Norden AB har en lignende kontrakt i dag.

      CompetitionSep 21, 2026
      Oct 26, 2026(16 days)

    • Sykehusinnkjøp Hf

      Laboratorie- og analyseutstyr

      Dynamisk innkjøpsordning for kjøp av PCR-instrumenter for levering til Helse Vest RHF og Helse Nord RHF

      Sykehusinnkjøp HF trenger leverandører av PCR-instrumenter for å levere til Helse Vest RHF og Helse Nord RHF i Nordland, Troms og Finnmark, Vestland, Svalbard til en verdi av 43 000 000 NOK. Anbudet gjelder etablering av en dynamisk innkjøpsordning hvor kvalifiserte leverandører kan tilby konvensjonell PCR og sanntid-PCR instrumenter til sykehusene under de nevnte helseregionene.

      Dynamic purchasing systemMar 20, 2024
      Apr 26, 2034(100+ days)
      NOK 43,000,000